期刊文献+

脱氢表雄酮对成骨细胞ERβ的上调节作用 被引量:4

Up-regulation of ERβ in Murine Osteoblasts with the Action of Dehydroepiandrosterone
下载PDF
导出
摘要 目的研究脱氢表雄酮(DHEA)对成骨细胞雌激素受体(ER)亚型的调节及防治绝经后骨质疏松的作用机制。方法取新生2—4dBALB/c小鼠颅骨,用酶消化法进行成骨细胞原代培养并鉴定。取原代培养的成骨细胞,模仿雌激素撤退现象后,给予不同时间1×100mol·L^-1的DHEA培养,透射电镜观察细胞器的变化,RT-PCR分析成骨细胞护骨素(OPG)/破骨细胞分化因子(RANKL),ER亚型的表达;同时分析ER亚型与OPG生成的相关性。结果1×10^-7mol·L^-1的DHEA使成骨细胞的细胞器更为丰富,糖原减少,高尔基体发达且分层增多;对成骨细胞ERα的表达无明显影响,却增高OPG/RANKL.ERβ的表达(均为P〈0.01),二者的表达水平呈明显正相关(P〈0.01)。结论DHEA能够增高OPG/RANKL的表达,从而抑制骨的吸收;其作用机制与ERβ的上调有关。 OBJECTIVE To investigate the up-regulation of ERβ in osteoblast and the mechanism for preventing and curing postmenopausal osteoporosis with dehydroepiandrosterone (DHEA), METHOI/S Mufine osteoblasts (OBs) from calvaria of neonatal BALB/c mice were cuhured and treated with 1 × 10^- 7 mol· L^- 1 DHEA at different time after the estrogen withdrawal. The biological characteristics of OBs were evaluated by transmission electroscope. The mRNA level of osteoprotegerin (0PG)/receptor activator of NF-κB ligand (RANKL) and estrogen receptor (ER) isoforms were detected by RT-PCR, The correlation between ER isoform and OPG/RANKL was analyzed, too, RESULTS With the action of 1 × 10^-7 mol· L^-1 DHEA. The OBs had more organdies and less glycogen, The expression of OPG/RANKL mRNA ( P 〈 0.01 ) and ERβ mRNA ( P 〈 0.01 ) in OBs was improved and the ratio of OPG/RANKL mRNA was positively related to the expression of ERβ mRNA ( P 〈 0.01 ), No significance was obtained in the expression of ERa. CONCLUSION DHEA can improve the expression of OPG/RANKL so as to inhibit the bone resorption of OC, which is mediated by the up-regulation of ERβ in OBs.
出处 《中国药学杂志》 CAS CSCD 北大核心 2006年第7期509-512,共4页 Chinese Pharmaceutical Journal
基金 国家自然科学基金资助项目(30472259) 上海市卫生局青年基金(044Y06)
关键词 脱氢表雄酮 成骨细胞 成骨细胞护骨素 雌激素受体 dehydroepiandrosterone osteoblast osteoprotegerin estrogen receptor
  • 相关文献

参考文献2

二级参考文献22

  • 1Arnett TR,Dempster DW.A comparative study of disaggregted chick and rat osteoclasts in vitro:effects of calcitonin and prostaglandins[J].Endocrinology,1987,120:602.
  • 2Lacey D,Timms E,Tan H,et al.Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation [J].Cell,1998,93:165.
  • 3Lamberts SW,van den Beld AW,van der Lely AJ.The endocrinology of aging [J].Science,1997,278:419.
  • 4Inoue S,Urano T,Ogawa S.Molecular cloning of rat efp:expression and regulation in primary osteoblasts[J].Biochem Biophys Res Commun,1999,261(2):412.
  • 5Kameda T,Mano H,Kumegawa M.Techniques for purification of rabbit osteoclasts and analysis of their functions [J].Nippon Yakurigaku Zasshi ,1997,109(2):75.
  • 6Lindunger A,Mackay CA,EK-RYlander B.Histochemistry and biochemistry of tartrate-resistant acid phosphatase and Tartrate-resistant acid adenosine triphosphatase in bone,bone marrow and spleen:impilcations for osteoclast ontogeny[J].Bone Miner,1990,10:109.
  • 7Wong B,RhoJJ,Arronet J,etal.TRANCE is anovel ligand of the tumor necrosis factor receptor family that activates C-Jun N-termind kinase in T cell[J].J Biol Chem,1997,272:25190.
  • 8Anderson D,Maraskovsky E,Billingsley W,et al.A homologue of the TNF receptor and its ligand enhance T cell growth and dendritic cell function[J].Nature,1997,390:175.
  • 9Kong Y,Yoshida H,Sarosi L,et al.OPGL is a key regulator of osteoclastogenesis,lymphocyte development and lymph node organogenesis[J].Nature,1999,397:315.
  • 10Yasuda H,Dhima N,Nakagawa N,et al.Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis inhibitory factor and is identical to TRANCE RANK [J].Proc Natl Acad Sci USA,1998,95:3597.

共引文献15

同被引文献49

引证文献4

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部